• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过靶向肠道微生物组治疗神经退行性疾病:从实验室到临床。

Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.

机构信息

Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, 400042, China.

Institute of Brain and Intelligence, Third Military Medical University, Chongqing, 400042, China.

出版信息

Transl Neurodegener. 2024 Feb 27;13(1):12. doi: 10.1186/s40035-024-00404-1.

DOI:10.1186/s40035-024-00404-1
PMID:38414054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10898075/
Abstract

The aetiologies and origins of neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD), are complex and multifaceted. A growing body of evidence suggests that the gut microbiome plays crucial roles in the development and progression of neurodegenerative diseases. Clinicians have come to realize that therapeutics targeting the gut microbiome have the potential to halt the progression of neurodegenerative diseases. This narrative review examines the alterations in the gut microbiome in AD, PD, ALS and HD, highlighting the close relationship between the gut microbiome and the brain in neurodegenerative diseases. Processes that mediate the gut microbiome-brain communication in neurodegenerative diseases, including the immunological, vagus nerve and circulatory pathways, are evaluated. Furthermore, we summarize potential therapeutics for neurodegenerative diseases that modify the gut microbiome and its metabolites, including diets, probiotics and prebiotics, microbial metabolites, antibacterials and faecal microbiome transplantation. Finally, current challenges and future directions are discussed.

摘要

神经退行性疾病(如阿尔茨海默病、帕金森病、肌萎缩侧索硬化症和亨廷顿病)的病因和起源复杂且多方面。越来越多的证据表明,肠道微生物组在神经退行性疾病的发展和进展中起着至关重要的作用。临床医生已经意识到,针对肠道微生物组的治疗方法有可能阻止神经退行性疾病的进展。本综述探讨了 AD、PD、ALS 和 HD 中肠道微生物组的改变,强调了肠道微生物组与神经退行性疾病中大脑之间的密切关系。评估了介导神经退行性疾病中肠道微生物组-大脑通讯的过程,包括免疫、迷走神经和循环途径。此外,我们总结了潜在的治疗神经退行性疾病的方法,这些方法可以改变肠道微生物组及其代谢物,包括饮食、益生菌和益生元、微生物代谢物、抗菌药物和粪便微生物组移植。最后,讨论了当前的挑战和未来的方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e39d/10898075/a7e83e330c5a/40035_2024_404_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e39d/10898075/0fd05df60387/40035_2024_404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e39d/10898075/a0bbd3e82448/40035_2024_404_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e39d/10898075/a7e83e330c5a/40035_2024_404_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e39d/10898075/0fd05df60387/40035_2024_404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e39d/10898075/a0bbd3e82448/40035_2024_404_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e39d/10898075/a7e83e330c5a/40035_2024_404_Fig3_HTML.jpg

相似文献

1
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.通过靶向肠道微生物组治疗神经退行性疾病:从实验室到临床。
Transl Neurodegener. 2024 Feb 27;13(1):12. doi: 10.1186/s40035-024-00404-1.
2
Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.肠脑轴失调及其对神经退行性疾病的可能贡献。
Neurotox Res. 2023 Dec 16;42(1):4. doi: 10.1007/s12640-023-00681-0.
3
The Microbiome as a Modifier of Neurodegenerative Disease Risk.肠道菌群作为神经退行性疾病风险的修饰因子。
Cell Host Microbe. 2020 Aug 12;28(2):201-222. doi: 10.1016/j.chom.2020.06.008.
4
The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances.肠道微生物组:在神经退行性疾病及其治疗进展中的重要作用。
Mol Cell Biochem. 2024 Sep;479(9):2217-2243. doi: 10.1007/s11010-023-04853-6. Epub 2023 Oct 3.
5
Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.理解肠脑轴及其对神经退行性疾病的治疗意义。
Nutrients. 2023 Oct 31;15(21):4631. doi: 10.3390/nu15214631.
6
Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.探讨肠道微生物群、代谢物与神经退行性疾病之间的偶然关联:一项孟德尔随机化研究。
J Alzheimers Dis. 2022;87(1):211-222. doi: 10.3233/JAD-215411.
7
The Relationship Between the Gut Microbiome and Neurodegenerative Diseases.肠道微生物组与神经退行性疾病的关系。
Neurosci Bull. 2021 Oct;37(10):1510-1522. doi: 10.1007/s12264-021-00730-8. Epub 2021 Jul 3.
8
Modification of the gut microbiome to combat neurodegeneration.肠道微生物组的修饰以对抗神经退行性变。
Rev Neurosci. 2019 Nov 26;30(8):795-805. doi: 10.1515/revneuro-2019-0005.
9
Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.肠道微生物群定义的阿尔茨海默病和帕金森病表观基因组揭示了新的治疗靶点。
Epigenomics. 2024 Jan;16(1):57-77. doi: 10.2217/epi-2023-0342. Epub 2023 Dec 13.
10
The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders.肠道微生物组在加剧和改善神经退行性疾病方面的双重作用。
Expert Rev Neurother. 2020 Jul;20(7):673-686. doi: 10.1080/14737175.2020.1775585. Epub 2020 Jun 27.

引用本文的文献

1
The microbiota-gut-brain axis and central nervous system diseases: from mechanisms of pathogenesis to therapeutic strategies.微生物群-肠-脑轴与中枢神经系统疾病:从发病机制到治疗策略
Front Microbiol. 2025 Jun 13;16:1583562. doi: 10.3389/fmicb.2025.1583562. eCollection 2025.
2
Reciprocal Interactions Between Periodontal Disease and Alzheimer's Disease: Implications for Mutual Triggering, Exacerbation, and Treatment Interventions-A Comprehensive Review of the Literature.牙周病与阿尔茨海默病之间的相互作用:对相互触发、病情加重及治疗干预的影响——文献综述
Neurol Int. 2025 May 24;17(6):81. doi: 10.3390/neurolint17060081.
3

本文引用的文献

1
Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury.口服粪便移植可富集lachnospiraceae 并增加丁酸以减轻急性肝损伤。
Cell Rep. 2024 Jan 23;43(1):113591. doi: 10.1016/j.celrep.2023.113591. Epub 2023 Dec 27.
2
Social anxiety disorder-associated gut microbiota increases social fear.社交焦虑障碍相关的肠道微生物群会增加社交恐惧。
Proc Natl Acad Sci U S A. 2024 Jan 2;121(1):e2308706120. doi: 10.1073/pnas.2308706120. Epub 2023 Dec 26.
3
Dietary fibre confers therapeutic effects in a preclinical model of Huntington's disease.
The Role of Livestock Antibiotic Use in Microbiota Dysbiosis and Neuroinflammation.
牲畜抗生素使用在微生物群失调和神经炎症中的作用。
Antibiotics (Basel). 2025 Jun 15;14(6):608. doi: 10.3390/antibiotics14060608.
4
Could a Mediterranean Diet Modulate Alzheimer's Disease Progression? The Role of Gut Microbiota and Metabolite Signatures in Neurodegeneration.地中海饮食能调节阿尔茨海默病的进展吗?肠道微生物群和代谢物特征在神经退行性变中的作用。
Foods. 2025 Apr 29;14(9):1559. doi: 10.3390/foods14091559.
5
KaiXinSan-JiaWei ameliorates cognitive dysfunction in APP/PS1 mice by intervening in gut microbiota and its metabolites.开心散加味通过干预肠道微生物群及其代谢产物改善 APP/PS1 小鼠的认知功能障碍。
Front Pharmacol. 2025 Apr 25;16:1483883. doi: 10.3389/fphar.2025.1483883. eCollection 2025.
6
Role of Antioxidants in Modulating the Microbiota-Gut-Brain Axis and Their Impact on Neurodegenerative Diseases.抗氧化剂在调节微生物群-肠-脑轴中的作用及其对神经退行性疾病的影响。
Int J Mol Sci. 2025 Apr 12;26(8):3658. doi: 10.3390/ijms26083658.
7
The Role of the Gastrointestinal Microbiota in Parkinson's Disease.胃肠道微生物群在帕金森病中的作用
Biomolecules. 2024 Dec 28;15(1):26. doi: 10.3390/biom15010026.
8
Gut-brain axis and environmental factors in Parkinson's disease: bidirectional link between disease onset and progression.帕金森病中的肠-脑轴与环境因素:疾病发生与进展之间的双向联系
Neural Regen Res. 2025 Dec 1;20(12):3416-3429. doi: 10.4103/NRR.NRR-D-24-00994. Epub 2024 Dec 16.
9
Immune mechanisms and shared immune targets in neurodegenerative diseases.神经退行性疾病中的免疫机制和共同免疫靶点
Nat Rev Neurol. 2025 Feb;21(2):67-85. doi: 10.1038/s41582-024-01046-7. Epub 2024 Dec 16.
10
Reverse engineering the Gut-Brain Axis and microbiome-metabolomics for symbiotic/pathogenic balance in neurodegenerative diseases.对肠道-大脑轴和微生物组-代谢组学进行逆向工程,以实现神经退行性疾病中共生/致病平衡。
Gut Microbes. 2024 Jan-Dec;16(1):2422468. doi: 10.1080/19490976.2024.2422468. Epub 2024 Nov 10.
膳食纤维在亨廷顿病的临床前模型中具有治疗作用。
Brain Behav Immun. 2024 Feb;116:404-418. doi: 10.1016/j.bbi.2023.12.023. Epub 2023 Dec 23.
4
Microglial Senescence and Activation in Healthy Aging and Alzheimer's Disease: Systematic Review and Neuropathological Scoring.小胶质细胞衰老和激活在健康衰老和阿尔茨海默病中的作用:系统评价和神经病理学评分。
Cells. 2023 Dec 12;12(24):2824. doi: 10.3390/cells12242824.
5
Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies.帕金森病与肠道微生物群:从临床到机制和治疗研究。
Transl Neurodegener. 2023 Dec 15;12(1):59. doi: 10.1186/s40035-023-00392-8.
6
Gut mucosal cells transfer α-synuclein to the vagus nerve.肠道黏膜细胞将α-突触核蛋白转移到迷走神经。
JCI Insight. 2023 Dec 8;8(23):e172192. doi: 10.1172/jci.insight.172192.
7
Efficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design.粪便微生物群移植治疗帕金森病的疗效:一项随机、安慰剂对照设计的临床试验结果。
Gut Microbes. 2023 Dec;15(2):2284247. doi: 10.1080/19490976.2023.2284247. Epub 2023 Dec 6.
8
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review.肠道微生物群失调与粪便微生物群移植的调节:伞状综述
Front Microbiol. 2023 Nov 3;14:1286429. doi: 10.3389/fmicb.2023.1286429. eCollection 2023.
9
Oral pathogens exacerbate Parkinson's disease by promoting Th1 cell infiltration in mice.口腔病原体通过促进 Th1 细胞浸润小鼠而加重帕金森病。
Microbiome. 2023 Nov 17;11(1):254. doi: 10.1186/s40168-023-01685-w.
10
Gut microbiome-targeted therapies for Alzheimer's disease.针对阿尔茨海默病的肠道微生物组靶向治疗。
Gut Microbes. 2023 Dec;15(2):2271613. doi: 10.1080/19490976.2023.2271613. Epub 2023 Nov 7.